Clinical trial · Interventional
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Internet Intervention for Sun Protection and Skin Self-check Behaviors
NCT03028948CI-TRIAL-00100816completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Conditions
Conditions (12)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stage 0 Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IA Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IB Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIA Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIB Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIC Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIIA Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIIB Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER | 0.78 |
| Stage IIIC Skin Melanoma | Cutaneous Melanoma | CURATED_BROADER |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Internet-Based Intervention | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I (ITW)
- description
- Patients access ITW and complete each module over 30-40 minutes. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
- interventionNames
- Other: Internet-Based Intervention
- Other: Questionnaire Administration
- Other: Survey Administration
- type
- ACTIVE_COMPARATOR
- label
- Arm II (usual care)
- description
- Patients receive usual care and are then offered ITW. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
- interventionNames
- Other: Questionnaire Administration
- Other: Survey Administration
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma * Phase I: From 3-36 months post-surgical treatment * Phase I: Access to the internet * Phase I: Able to speak and read English * Phase I: Able to provide informed consent * Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma * Phase II: From 3-24 months post-surgical treatment * Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at least once during the past 2 months) * Phase II: Not adherent to sun protection recommendations (i.e., mean score \< 4 \[which corresponds to "often"\] on a 5-point scale \[from 1 = "never" to 5 = "always"\] that assesses the frequency of engaging in four sun protection behaviors) * Phase II: Access to a computer connected to the internet * Phase II: Able to speak and read English * Phase II: Able to provide informed consent
References
Publications (1)
- DERIVEDCoups EJ, Manne SL, Ohman Strickland P, Hilgart M, Goydos JS, Heckman CJ, Chamorro P, Rao BK, Davis M, Smith FO, Thorndike FP, Ritterband LM. Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics. Contemp Clin Trials. 2019 Aug;83:117-127. doi: 10.1016/j.cct.2019.06.014. Epub 2019 Jun 27. PMID 31255801